CHROMATIN ACTIVATION PROFILING OF STEREOTYPED CHRONIC LYMPHOCYTIC LEUKEMIAS REVEALS A SUBSET #8 SPECIFIC SIGNATURE
Blood · 2023
DOI: 10.1182/blood.2022016587 ↗Kurz gefasst
Fachartikel in der Zeitschrift Blood, 2023. Verfasst von Maria Tsagiopoulou und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece. Hauptthemen laut MEDLINE: Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
The chromatin activation landscape of chronic lymphocytic leukemia (CLL) with stereotyped B-cell receptor immunoglobulin is currently unknown. Here, we report the results of a whole-genome chromatin profiling of histone 3 lysine 27 acetylation of 22 CLLs from major subsets which were compared against non-stereotyped CLLs and normal B cell subpopulations. Although subsets #1, #2, and #4 did not differ much from their non-stereotyped CLL counterparts, subset #8 displayed a remarkably distinct chromatin activation profile. In particular, we identified 209 de novo active regulatory elements in this subset, which showed similar patterns with U-CLLs undergoing Richter transformation. These regions were enriched for binding sites of 9 overexpressed transcription factors. In 78/209 regions, we identified 113 candidate overexpressed target genes, being 11 regions associated with more than two adjacent genes. These included blocks of up to 7 genes, suggesting a local co-upregulation within the same genome compartment. Our findings further underscore the uniqueness of subset #8 CLLs, notable for the highest risk of Richter's transformation amongst all CLL, and provide additional clues to decipher the molecular basis of its clinical behavior.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.
- Centro Nacional de Análisis Genómico, Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain.
- Institut d'Investigacions Biomèdiques August Pi i Sunyer, Universitat de Barcelona, Barcelona, Spain.
- Centro de Investigación Biomédica en Red de Cáncer, Spain.
- Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
- Departamento de Fundamentos Clínicos, Universitat de Barcelona, Barcelona, Spain.
ORCID-Profile: Maria Tsagiopoulou, Vicente Chapaprieta, Beatriz García-Torre, Nikolaos Pechlivanis, Ferran Nadeu, Fotis Psomopoulos, Elías Campo
Zitieren
APA
Tsagiopoulou, M., Chapaprieta, V., Russiñol, N., García-Torre, B., Pechlivanis, N., Nadeu, F., Papakonstantinou, N., Stavroyianni, N., Chatzidimitriou, A., Psomopoulos, F., Campo, E., Stamatopoulos, K., & Martín-Subero, J. I. (2023). CHROMATIN ACTIVATION PROFILING OF STEREOTYPED CHRONIC LYMPHOCYTIC LEUKEMIAS REVEALS A SUBSET #8 SPECIFIC SIGNATURE. Blood. https://doi.org/10.1182/blood.2022016587
Vancouver
Tsagiopoulou M, Chapaprieta V, Russiñol N, García-Torre B, Pechlivanis N, Nadeu F, et al. CHROMATIN ACTIVATION PROFILING OF STEREOTYPED CHRONIC LYMPHOCYTIC LEUKEMIAS REVEALS A SUBSET #8 SPECIFIC SIGNATURE. Blood. 2023. doi:10.1182/blood.2022016587
BibTeX
@article{Tsagiopoulou2023,
author = {Tsagiopoulou, Maria and Chapaprieta, Vicente and Russiñol, Nuria and García-Torre, Beatriz and Pechlivanis, Nikolaos and Nadeu, Ferran and Papakonstantinou, Nikos and Stavroyianni, Niki and Chatzidimitriou, Anastasia and Psomopoulos, Fotis and Campo, Elías and Stamatopoulos, Kostas and Martín-Subero, José Ignacio},
title = {CHROMATIN ACTIVATION PROFILING OF STEREOTYPED CHRONIC LYMPHOCYTIC LEUKEMIAS REVEALS A SUBSET #8 SPECIFIC SIGNATURE},
journal = {Blood},
year = {2023},
doi = {10.1182/blood.2022016587}
}
EUVIMED